NCT02713542View on ClinicalTrials.gov

Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 2, 2018

Study Completion Date

August 30, 2018

Conditions
Osteoarthritis
Interventions
DEVICE

ACP

Autologous Conditioned Plasma

OTHER

Placebo

Three Normal Saline IA injections of 3-8 mL at 1-week intervals.

Trial Locations (4)

29615

Hawkins Foundation, Greenville

48106

MedSport University of Michigan Sports Medicine, Ann Arbor

60612

Rush University Medical Center, Chicago

65201

Columbia Orthopedic Group, Columbia

Sponsors

Lead Sponsor

Arthrex, Inc.
All Listed Sponsors
lead

Arthrex, Inc.

INDUSTRY

NCT02713542 - Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA) | Biotech Hunter | Biotech Hunter